Actavis scoops rival for €62bn

A Dublin-headquartered pharmaceutical giant has completed its takeover of a US rival for $66bn (€62bn).

Actavis sealed the deal to acquire Allergan in a cash and equity transaction in a move that catapults the combined entity into the world’s top 10 pharma firms by sales revenue.

The acquisition went through after the European Commission gave it its blessing, removing the final hurdle to its completion.